VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-1.04%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$165M
AUM Growth
-$4.08M
(-2.4%)
Cap. Flow
+$1.01M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
6.09%
Holding
488
New
53
Increased
73
Reduced
307
Closed
54
Top Buys
| 1 |
Halliburton
HAL
|
$819K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$814K |
| 3 |
Steel Dynamics
STLD
|
$798K |
| 4 |
Caterpillar
CAT
|
$792K |
| 5 |
Booking.com
BKNG
|
$789K |
Top Sells
| 1 |
Netflix
NFLX
|
$1.05M |
| 2 |
Vulcan Materials
VMC
|
$1.01M |
| 3 |
CoStar Group
CSGP
|
$998K |
| 4 |
Eli Lilly
LLY
|
$967K |
| 5 |
Ingersoll Rand
IR
|
$913K |
Sector Composition
| 1 | Healthcare | 18.63% |
| 2 | Financials | 17.26% |
| 3 | Technology | 14.89% |
| 4 | Energy | 9.42% |
| 5 | Consumer Discretionary | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
uniQure
QURE
$985M
| $34.2K | 0.02% |
5,104
-507
| -9% | -$3.4K |
|
427
Stoke Therapeutics
STOK
$1.13B
| $31.1K | 0.02% |
7,893
-785
| -9% | -$3.09K |
|
428
TG Therapeutics
TGTX
$5.11B
| $30.4K | 0.02% |
3,634
-367
| -9% | -$3.07K |
|
429
Scilex Holding
SCLX
$159M
| $22.2K | 0.01% |
504
| – | – |
|
430
Kodiak Sciences
KOD
$556M
| $19.7K | 0.01% |
10,947
-1,095
| -9% | -$1.97K |
|
431
Liberty Live Group Series C
LLYVK
$8.88B
| $14K | 0.01% |
+437
| New | +$14K |
|
432
Mersana Therapeutics
MRSN
$34M
| $13.2K | 0.01% |
414
-41
| -9% | -$1.3K |
|
433
BioXcel Therapeutics
BTAI
$55.2M
| $11.8K | 0.01% |
290
-29
| -9% | -$1.18K |
|
434
FibroGen
FGEN
$48.9M
| $5.21K | ﹤0.01% |
241
-24
| -9% | -$519 |
|
435
Agilent Technologies
A
$36.5B
| – | – |
-5,704
| Closed | -$686K |
|
436
AbbVie
ABBV
$375B
| – | – |
-4,785
| Closed | -$645K |
|
437
Autodesk
ADSK
$69.5B
| – | – |
-3,973
| Closed | -$813K |
|
438
Air Products & Chemicals
APD
$64.5B
| – | – |
-2,643
| Closed | -$792K |
|
439
Blackrock
BLK
$170B
| – | – |
-1,110
| Closed | -$767K |
|
440
Bristol-Myers Squibb
BMY
$96B
| – | – |
-11,124
| Closed | -$711K |
|
441
Chubb
CB
$111B
| – | – |
-3,794
| Closed | -$731K |
|
442
C.H. Robinson
CHRW
$14.9B
| – | – |
-7,964
| Closed | -$751K |
|
443
Cooper Companies
COO
$13.5B
| – | – |
-8,020
| Closed | -$769K |
|
|
444
CoStar Group
CSGP
$37.9B
| – | – |
-11,210
| Closed | -$998K |
|
445
Corteva
CTVA
$49.1B
| – | – |
-12,495
| Closed | -$716K |
|
446
Dollar General
DG
$24.1B
| – | – |
-3,548
| Closed | -$602K |
|
447
DexCom
DXCM
$31.6B
| – | – |
-6,328
| Closed | -$813K |
|
448
Electronic Arts
EA
$42.2B
| – | – |
-6,004
| Closed | -$779K |
|
|
ECC
449
Eagle Point Credit Co
ECC
$954M
| – | – |
-38,267
| Closed | -$389K |
|
450
Elevance Health
ELV
$70.6B
| – | – |
-1,702
| Closed | -$756K |
|